165 related articles for article (PubMed ID: 34917314)
1. Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome.
Vasant DH; Hasan SS; Cruickshanks P; Whorwell PJ
Frontline Gastroenterol; 2021; 12(7):570-577. PubMed ID: 34917314
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.
Devenney J; Hasan SS; Morris J; Whorwell PJ; Vasant DH
Aliment Pharmacol Ther; 2024 Jan; 59(2):269-277. PubMed ID: 37927144
[TBL] [Abstract][Full Text] [Related]
3. Experience and clinical efficacy of gut-directed hypnotherapy in an Asian population with refractory irritable bowel syndrome.
Sasegbon A; Hasan SS; Whorwell PJ; Vasant DH
JGH Open; 2022 Jul; 6(7):447-453. PubMed ID: 35822122
[TBL] [Abstract][Full Text] [Related]
4. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.
Hoekman DR; Vlieger AM; Stokkers PC; Mahhmod N; Rietdijk S; de Boer NK; de Meij TG; Frankenhuis C; D'Haens GR; Benninga MA
J Crohns Colitis; 2021 Jul; 15(7):1106-1113. PubMed ID: 33245332
[TBL] [Abstract][Full Text] [Related]
5. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients.
Miller V; Carruthers HR; Morris J; Hasan SS; Archbold S; Whorwell PJ
Aliment Pharmacol Ther; 2015 May; 41(9):844-55. PubMed ID: 25736234
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
Peter J; Fournier C; Keip B; Rittershaus N; Stephanou-Rieser N; Durdevic M; Dejaco C; Michalski M; Moser G
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453528
[TBL] [Abstract][Full Text] [Related]
7. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
Lackner JM; Ma CX; Keefer L; Brenner DM; Gudleski GD; Satchidanand N; Firth R; Sitrin MD; Katz L; Krasner SS; Ballou SK; Naliboff BD; Mayer EA
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1147-57. PubMed ID: 23524278
[TBL] [Abstract][Full Text] [Related]
8. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
9. Biofeedback for treatment of irritable bowel syndrome.
Goldenberg JZ; Brignall M; Hamilton M; Beardsley J; Batson RD; Hawrelak J; Lichtenstein B; Johnston BC
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31713856
[TBL] [Abstract][Full Text] [Related]
10. The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic.
Noble H; Hasan SS; Whorwell PJ; Vasant DH
Neurogastroenterol Motil; 2022 Sep; 34(9):e14347. PubMed ID: 35238428
[TBL] [Abstract][Full Text] [Related]
11. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
[TBL] [Abstract][Full Text] [Related]
12. Comparison of digitally-delivered gut-directed hypnotherapy program to an active control for irritable bowel syndrome.
Anderson EJ; Peters SL; Gibson PR; Halmos EP
Am J Gastroenterol; 2024 Jun; ():. PubMed ID: 38940439
[TBL] [Abstract][Full Text] [Related]
13. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.
Lövdahl J; Törnblom H; Ringström G; Palsson OS; Simrén M
Aliment Pharmacol Ther; 2022 Jun; 55(12):1501-1511. PubMed ID: 35505463
[TBL] [Abstract][Full Text] [Related]
14. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W
Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384
[TBL] [Abstract][Full Text] [Related]
15. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
Lindfors P; Ljótsson B; Bjornsson E; Abrahamsson H; Simrén M
Neurogastroenterol Motil; 2013 Feb; 25(2):169-e86. PubMed ID: 23051178
[TBL] [Abstract][Full Text] [Related]
16. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
[TBL] [Abstract][Full Text] [Related]
17. [Bidirectional regulation of acupuncture: a subgroup analysis of multicenter randomized controlled trial of acupuncture with
Guo J; Sun JH; Chen L; Geng H; Yang GH; Shen RR; Ding M; Lu J; Liu L; Fang XD; Pei LX
Zhongguo Zhen Jiu; 2021 Aug; 41(8):845-50. PubMed ID: 34369692
[TBL] [Abstract][Full Text] [Related]
18. Pilot-RCT of an integrative group therapy for patients with refractory irritable bowel syndrome (ISRCTN02977330).
Berens S; Stroe-Kunold E; Kraus F; Tesarz J; Gauss A; Niesler B; Herzog W; Schaefert R
J Psychosom Res; 2018 Feb; 105():72-79. PubMed ID: 29332637
[TBL] [Abstract][Full Text] [Related]
19. Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial.
Pazhouh HK; Hosseini SMA; Taghipour A; Hamedi S; Noras M
Chin J Integr Med; 2020 Oct; 26(10):729-735. PubMed ID: 32623701
[TBL] [Abstract][Full Text] [Related]
20. Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
Kawamura Y; Yamamoto S; Funaki Y; Ohashi W; Yamamoto K; Ozeki T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Ogasawara N; Sasaki M; Kasugai K
J Gastroenterol; 2020 Jan; 55(1):27-38. PubMed ID: 31428873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
